<?xml version="1.0"?>

<rss version="2.0">
   <channel>
      <title><![CDATA[releases feed for ERT]]></title>
      <link>http://www.realwire.com/</link>
      <description><![CDATA[Most recent 15 articles distributed for ERT by RealWire]]></description>
      <language>en-gb</language>
      <lastBuildDate>Thu, 23 May 2013 00:00:01 +0100</lastBuildDate>
      <docs>http://blogs.law.harvard.edu/tech/rss</docs>
      <category>News</category>
      <managingEditor>enquiries@realwire.com (RealWire)</managingEditor>
      <copyright>Copyright (c) 2013 Realwire Limited</copyright>
	  <ttl>60</ttl>
      <image>
        <title>RealWire</title>
        <url>http://www.realwire.com/images/headLogo.gif</url>
        <link>http://www.realwire.com/</link>
      </image>

      <item>
         <title>ERT Launches New Website to Support Significant Commercial Growth</title>
		 <link>http://www.realwire.com/releases/ERT-Launches-New-Website-to-Support-Significant-Commercial-Growth</link>
         <description><![CDATA[PHILADELPHIA, PA, 15 February - ERT, a global technology-driven provider of health outcomes services and customizable medical devices to biopharmaceutical sponsors and Contract Research Organizations (CROs), announced today the launch of a new corporate website to further elevate its market and thought leadership position. Complementing the company's commercial growth in the last 18 months, web traffic to ERT's website increased by 41% from June 2010 to October 2011, as visitors sought further detailed information about...

Source: RealWire]]></description>
         <pubDate>Wed, 15 Feb 2012 14:08:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Launches-New-Website-to-Support-Significant-Commercial-Growth</guid>
      </item>
  
      <item>
         <title>ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients</title>
		 <link>http://www.realwire.com/releases/ERT-and-UCLA-Initiate-Innovative-Pilot-Program-for-Chronically-Ill-Patients</link>
         <description><![CDATA[More than 150 patients with COPD will receive additional health care services to improve their health and lower the costs of long term care.Program will test the benefits of remote monitoring services on a needy and growing population.PHILADELPHIA, February 08, 2012 - ERT, a global technology-driven provider of health outcomes services and customizable medical devices to biopharmaceutical sponsors and Contract Research Organizations (CROs), announces the launch of the CLEAR Study in collaboration with UCLA, an...

Source: RealWire]]></description>
         <pubDate>Wed, 08 Feb 2012 16:06:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-and-UCLA-Initiate-Innovative-Pilot-Program-for-Chronically-Ill-Patients</guid>
      </item>
  
      <item>
         <title>ERT Appoints Linda Deal Head of Health Outcomes Research</title>
		 <link>http://www.realwire.com/releases/ERT-Appoints-Linda-Deal-Head-of-Health-Outcomes-Research</link>
         <description><![CDATA[PHILADELPHIA, PA, 25 August 2011- ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today the appointment of Linda Deal to lead ERT's Health Outcomes Research initiatives. This strategic appointment extends ERT's commitment to health outcomes research and augments its Patient Reported Outcomes capabilities and multi modality product offering with deeper scientific expertise. Jeffrey Litwin MD, President and CEO of ERT comments, "Linda's expertise and extensive...

Source: RealWire]]></description>
         <pubDate>Thu, 25 Aug 2011 14:46:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Appoints-Linda-Deal-Head-of-Health-Outcomes-Research</guid>
      </item>
  
      <item>
         <title>ERT Appoints Robert Kleiman MD to Chief Medical Officer</title>
		 <link>http://www.realwire.com/releases/ERT-Appoints-Robert-Kleiman-MD-to-Chief-Medical-Officer</link>
         <description><![CDATA[PHILADELPHIA, PA - 23 June, 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that Robert Kleiman, M.D. has been appointed to the role of Chief Medical Officer in addition to his current role as Vice President of Global Cardiology. Dr. Kleiman graduated from Brown University Medical School with residency in Internal Medicine and completed Fellowships in Cardiology and Cardiac Electrophysiology at the University...

Source: RealWire]]></description>
         <pubDate>Thu, 23 Jun 2011 12:26:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Appoints-Robert-Kleiman-MD-to-Chief-Medical-Officer</guid>
      </item>
  
      <item>
         <title>ERT Awarded over $10 Million of ePRO Business from Major Pharma &#8211; Increasing its Position as a Leading ePRO Provider</title>
		 <link>http://www.realwire.com/releases/ERT-Awarded-over-10-Million-of-ePRO-Business-from-Major-Pharma--Increasing-its-Position-as-a-Leading-ePRO-Provider</link>
         <description><![CDATA[PHILADELPHIA, PA - 14 April 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that it was awarded three new contracts with top tier pharmaceutical companies, totaling over $10 million for its electronic patient reported outcomes (ePRO) business. The company has been selected to provide its diverse multi-modality solutions, reinforcing its position as a leading provider of multi-mode ePRO devices and services. ERT is...

Source: RealWire]]></description>
         <pubDate>Thu, 14 Apr 2011 15:47:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Awarded-over-10-Million-of-ePRO-Business-from-Major-Pharma--Increasing-its-Position-as-a-Leading-ePRO-Provider</guid>
      </item>
  
      <item>
         <title>ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO</title>
		 <link>http://www.realwire.com/releases/ERT-Announces-the-Appointment-of-Joel-Morganroth-MD-as-Interim-CEO</link>
         <description><![CDATA[PHILADELPHIA, PA, 21 December 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010. Dr. Joel Morganroth, currently ERT's Chairman and Chief Scientific Officer, has also been elected by the Board as President and CEO until ERT hires a permanent CEO. Dr. Morganroth...

Source: RealWire]]></description>
         <pubDate>Tue, 21 Dec 2010 13:22:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Announces-the-Appointment-of-Joel-Morganroth-MD-as-Interim-CEO</guid>
      </item>
  
      <item>
         <title>ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors</title>
		 <link>http://www.realwire.com/releases/ERT-Unveils-Full-Range-of-ePRO-Solutions-Providing-the-Power-of-Choice-for-Clinical-Trial-Sponsors</link>
         <description><![CDATA[PHILADELPHIA, PA, 16 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market continues to grow, ePRO tools have increasingly become more sophisticated, with their development reflecting the diverse needs of sponsors and facilitating compliance by the patient. ERT now offers a broad range of proven modalities of technology,...

Source: RealWire]]></description>
         <pubDate>Thu, 16 Dec 2010 15:57:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Unveils-Full-Range-of-ePRO-Solutions-Providing-the-Power-of-Choice-for-Clinical-Trial-Sponsors</guid>
      </item>
  
      <item>
         <title>ERT Facilitates Global Growth with Appointment of Klaus Besier to Board of Directors</title>
		 <link>http://www.realwire.com/releases/ERT-Facilitates-Global-Growth-with-Appointment-of-Klaus-Besier-to-Board-of-Directors</link>
         <description><![CDATA[Industry Expert Brings Significant Record of Executive Leadership in Sales, Marketing and Global Business Development to Growing CompanyPHILADELPHIA, PA 14 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Klaus Besier to the Company's Board of Directors. This strategic appointment will enable ERT to draw on Mr. Besier's extensive experience and international perspective in helping companies develop, implement and execute global...

Source: RealWire]]></description>
         <pubDate>Tue, 14 Dec 2010 15:09:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ERT-Facilitates-Global-Growth-with-Appointment-of-Klaus-Besier-to-Board-of-Directors</guid>
      </item>
  
      <item>
         <title>Chairman and Chief Scientist at ERT Recognized as One of 100 Most Inspiring People in the Life Sciences Industry</title>
		 <link>http://www.realwire.com/releases/Chairman-and-Chief-Scientist-at-ERT-Recognized-as-One-of-100-Most-Inspiring-People-in-the-Life-Sciences-Industry</link>
         <description><![CDATA[PHILADELPHIA, PA 10 August 2010 - ERT, a leading provider of centralized services to global pharmaceutical, biotechnology and medical device companies, announces that Joel Morganroth, MD, Chairman and Chief Scientist, has been acknowledged by PharmaVOICE magazine as one of the 100 most inspiring people in the life sciences industry. Dr. Morganroth has been recognized for his lifetime contribution to the advancement of individuals and science and the welfare of patients. The PharmaVOICE 100 winners are...

Source: RealWire]]></description>
         <pubDate>Tue, 10 Aug 2010 15:00:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/Chairman-and-Chief-Scientist-at-ERT-Recognized-as-One-of-100-Most-Inspiring-People-in-the-Life-Sciences-Industry</guid>
      </item>
  
      <item>
         <title>ERT Industry Poll and Sponsor Endorsement Confirms eC-SSRS is an Effective Method of Suicidality Monitoring in Clinical Trials</title>
		 <link>http://www.realwire.com/releases/ert-industry-poll-and-sponsor-endorsement-confirms-ec-ssrs-is-an-effective-method-of-suicidality-mon</link>
         <description><![CDATA[PHILADELPHIA, PA 30 June 2010 ERT, a leading provider of centralized services to global pharmaceutical, biotechnology and medical device companies, announces that a recent survey of over 250 respondents reported that all clinicians polled found the Columbia Suicide Severity Rating Scale (C-SSRS) to be an effective method for prospectively monitoring suicidality. Furthermore, 99% of respondents thought the self-rated eC-SSRS would be an effective approach to meeting this new regulatory requirement. The eC-SSRS is a pioneering...

Source: RealWire]]></description>
         <pubDate>Wed, 30 Jun 2010 14:00:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-industry-poll-and-sponsor-endorsement-confirms-ec-ssrs-is-an-effective-method-of-suicidality-mon</guid>
      </item>
  
      <item>
         <title>ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services</title>
		 <link>http://www.realwire.com/releases/ert-announces-new-report-by-tufts-identifying-growth-in-adoption-of-centralized-ecg-services</link>
         <description><![CDATA[PHILADELPHIA, 21 June 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing adoption of centralized ECG (electrocardiogram) services. The industry-wide report measures the current and anticipated adoption levels of centralized ECGs in clinical trials. This document, entitled "Mapping Adoption of Centralized Cardiac Safety Assessment,"...

Source: RealWire]]></description>
         <pubDate>Mon, 21 Jun 2010 14:01:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-announces-new-report-by-tufts-identifying-growth-in-adoption-of-centralized-ecg-services</guid>
      </item>
  
      <item>
         <title>ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation</title>
		 <link>http://www.realwire.com/releases/ert-closes-the-acquisition-of-the-research-services-division-of-carefusion-corporation</link>
         <description><![CDATA[PHILADELPHIA, PA, 01 June 2010. ERT (eResearchTechnology, Inc.), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced the successful closing of the acquisition of the Research Services Division of CareFusion Corporation (CRS). CRS is a leading provider of respiratory diagnostics services and manufacturer of diagnostic devices and also offers cardiac safety and ePRO services. The combined company offers a market leading position in the clinical research market for...

Source: RealWire]]></description>
         <pubDate>Tue, 01 Jun 2010 16:21:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-closes-the-acquisition-of-the-research-services-division-of-carefusion-corporation</guid>
      </item>
  
      <item>
         <title>ERT Agrees to Acquire the Research Services Business of CareFusion</title>
		 <link>http://www.realwire.com/releases/ert-agrees-to-acquire-the-research-services-business-of-carefusion</link>
         <description><![CDATA[PHILADELPHIA, PA, 30 April 2010. ERT (NASDAQ: ERES), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today that it has agreed to acquire the research services division of CareFusion Corporation (CRS), for $81 million in cash. CRS is a leading provider of respiratory diagnostics services and manufacturer of diagnostic devices and also offers cardiac safety and ePRO services. All will be integrated into ERT's existing business. ERT...

Source: RealWire]]></description>
         <pubDate>Fri, 30 Apr 2010 11:00:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-agrees-to-acquire-the-research-services-business-of-carefusion</guid>
      </item>
  
      <item>
         <title>ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers </title>
		 <link>http://www.realwire.com/releases/ert-demonstrates-patient-safety-expertise-in-clinical-trials-with-new-knowledge-series-of-papers</link>
         <description><![CDATA[PHILADELPHIA, 15 January 2010 - ERT (NASDAQ, ERES), a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry. The papers are now available to download from...

Source: RealWire]]></description>
         <pubDate>Fri, 15 Jan 2010 12:10:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-demonstrates-patient-safety-expertise-in-clinical-trials-with-new-knowledge-series-of-papers</guid>
      </item>
  
      <item>
         <title>ERT Appoints Senior Executive for Health Care Market and Acquisition Opportunities</title>
		 <link>http://www.realwire.com/releases/ert-appoints-senior-executive-for-health-care-market-and-acquisition-opportunities</link>
         <description><![CDATA[PHILADELPHIA, 11 January 2010 - ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, announced the appointment of John Sory to the newly created role of Senior Vice President of Health Care Solutions. This strategic appointment will enable ERT to leverage its core expertise into the larger health care market. Mr. Sory will be responsible for developing this growth area as well as exploring merger and acquisition opportunities in...

Source: RealWire]]></description>
         <pubDate>Mon, 11 Jan 2010 15:45:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/ert-appoints-senior-executive-for-health-care-market-and-acquisition-opportunities</guid>
      </item>
  
   </channel>
</rss>
